Skip to main content

What the FDA labels say about taking them together

Digoxin and glycopyrrolate

Glycopyrrolate's FDA label (Cuvposa) of December 19, 2024 names digoxin in its drug interactions section; the digoxin labels PlainMeds reads (3) do not name glycopyrrolate. The glycopyrrolate label: “DRUG INTERACTIONS Digoxin tablets: Use with glycopyrrolate can increase digoxin serum levels.”

Check it at the source: the digoxin FDA label on DailyMed (effective December 5, 2024, Advanz Pharma (US) Corp.); the glycopyrrolate FDA label on DailyMed (effective October 9, 2025, Hikma Pharmaceuticals USA Inc.).

What does the digoxin label say about glycopyrrolate?

Digoxin's label (effective December 5, 2024) and its 2 other brand-application labels do not name glycopyrrolate in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (LANOXIN), Advanz Pharma (US) Corp., effective December 5, 2024 (SPL set d91e3646-4c63-4512-ab22-db39c085c4dc), via openFDA; the full label on DailyMed

What does the glycopyrrolate label say about digoxin?

Cuvposa label (Merz Pharmaceuticals, LLC, December 19, 2024), drug interactions

DRUG INTERACTIONS Digoxin tablets: Use with glycopyrrolate can increase digoxin serum levels.

Source: FDA drug label (Cuvposa, NDA022571), Merz Pharmaceuticals, LLC, effective December 19, 2024 (SPL set d200bd44-9856-4104-a29e-a4cca3db6737), via openFDA

Source: FDA drug label (Glycopyrrolate), Hikma Pharmaceuticals USA Inc., effective October 9, 2025 (SPL set 960d2dd0-008d-4ec1-ba2e-9388b28b23e2), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

26Digoxin generic labelers
58Glycopyrrolate generic labelers
DigoxinGlycopyrrolate
Labeled forHeart failure, Atrial fibrillationn/a
Boxed warningNoNo
Pharmacy cost (NADAC)$0.133 per tablet 125 mcg tablet$1.51 per mL 0.2 mg/mL vial
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?